ドラッグデリバリーの世界市場レポート 2025年

ドラッグデリバリー市場規模は、今後数年間で力強い成長が見込まれます。2029年には2兆4,973億3,000万米ドルに成長し、CAGRは7.1%となります。予測期間の成長は、薬剤の自己投与に対する需要の高まり、在宅ヘルスケアの導入拡大、標的ドラッグデリバリーに対する需要の高まり、高齢者数の増加、ドラッグデリバリー技術に対する規制支援などに起因すると考えられます。予測期間における主な動向としては、ドラッグデリバリー技術の進歩、遠隔医療との統合、ドラッグデリバリーにおける3Dプリンティング、標的ドラッグデリバリーシステム、連続製造プロセスなどが挙げられます。

予測される慢性疾患の増加は、当面のドラッグデリバリー市場の成長を促進します。「慢性疾患の有病率」という用語は、ある時点で特定の集団内に存在する慢性疾患の症例の総数を示します。ドラッグデリバリーは、様々な症状を治療するために身体の特定の部位に医薬品を投与することで、慢性疾患に苦しむ患者を助けるという重要な役割を担っています。例えば、世界保健機関（WHO）の報告によると、非伝染性疾患は年間4,100万人の死亡の原因となっており、全世界の死亡者数の71％を占め、中でも心血管疾患が主な原因となっています。したがって、慢性疾患の蔓延が増加していることが、ドラッグデリバリー市場の成長を促進する重要な要因となっています。

遠隔医療サービスの継続的な拡大は、ドラッグデリバリー市場の成長に貢献すると予想されます。遠隔医療は、通信機器やデジタルプラットフォームなどの技術を活用して、遠隔地から患者にヘルスケアに関するアドバイスや評価、治療、フォローアップを提供するものです。ドラッグデリバリーシステムと遠隔医療を融合させることで、ヘルスケアデリバリーの効率が向上し、患者が医療従事者や施設と地理的に離れていても、必要な薬剤やサポート、アドバイスを受けられるようになります。例えば、2022年8月、Australian Digital Health Agencyは、2020年3月から2022年7月までの間に、1億1,820万件の遠隔医療サービスが1,800万人に提供されました。現在9万5,000人以上の開業医が遠隔医療サービスを利用しています。このように、遠隔医療サービスの採用が増加していることが、ドラッグデリバリー市場の原動力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のドラッグデリバリー市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のドラッグデリバリー市場：成長率分析
• 世界のドラッグデリバリー市場の実績：規模と成長、2019～2024年
• 世界のドラッグデリバリー市場の予測：規模と成長、2024～2029年、2034年
• 世界のドラッグデリバリー総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のドラッグデリバリー市場：投与経路別、実績と予測、2019～2024年、2024～2029年、2034年
• 経口
• 眼
• 肺
• 鼻
• 注射剤
• 外用剤
• その他
• 世界のドラッグデリバリー市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 感染症
• がん
• 心血管疾患
• 糖尿病
• 呼吸器疾患
• 中枢神経系疾患
• 自己免疫疾患
• その他の用途
• 世界のドラッグデリバリー市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院
• ホームケア設定
• ASC/クリニック
• その他のエンドユーザー
• 世界のドラッグデリバリー市場：経口のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 錠剤
• カプセル
• 液体
• 粉末
• 世界のドラッグデリバリー市場：眼のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 目薬
• 眼内挿入物
• 眼内インプラント
• 世界のドラッグデリバリー市場：肺のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 定量噴霧式吸入器（MDI）
• ドライパウダー吸入器（DPI）
• ネブライザー
• 世界のドラッグデリバリー市場：鼻のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 鼻用スプレー
• 鼻用ジェル
• 鼻用パウダー
• 世界のドラッグデリバリー市場：注射剤のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 静脈注射（IV）
• 筋肉内注射（IM）
• 皮下注射（SC）
• 生物製剤とバイオシミラー
• 世界のドラッグデリバリー市場：外用剤のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• クリーム
• 軟膏
• ジェル
• 経皮パッチ
• 世界のドラッグデリバリー市場：その他のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 舌下
• バッカル
• 直腸
• 鼻腔内

第7章 地域別・国別分析

• 世界のドラッグデリバリー市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界のドラッグデリバリー市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ドラッグデリバリー市場：競合情勢
• ドラッグデリバリー市場：企業プロファイル
  • 3M Company. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Becton Dickinson And Company
• C. H. Boehringer Sohn AG & Co. KG
• Boston Scientific Corporation
• Bristol-Myers Squibb Company
• Consort Medical plc
• Eli Lilly and Company
• Emergent Biosolutions Inc.
• F. Hoffmann-La Roche AG
• GlaxoSmithKline plc
• Johnson & Johnson
• Kite Pharma Inc.
• Merck & Co Inc.
• Nemera France SAS
• Novartis AG
• Pfizer Inc

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ドラッグデリバリー市場2029：新たな機会を提供する国
• ドラッグデリバリー市場2029：新たな機会を提供するセグメント
• ドラッグデリバリー市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Pharmaceutical drug delivery refers to the process or method of administering a drug to an animal or human to achieve a therapeutic effect. It is a formulation or apparatus that allows a medicinal material to target its site of action while avoiding non-target cells, organs, or tissues.

The main types of pharmaceutical drug delivery routes of administration are oral, ocular, pulmonary, nasal, injectable, topical, and other routes. The oral route refers to the administration of a drug through the mouth, which is the most common route for drug administration due to its sustained and controlled delivery, ease of administration, and feasibility for solid dosage forms. The different pharmaceutical drug delivery applications include infectious diseases, cancer, cardiovascular diseases, diabetes, respiratory diseases, central nervous system disorders, autoimmune diseases, and other applications. The different end-users include hospitals, home care settings, ASC/Clinics, and other end users.

The pharmaceutical drug delivery market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical drug delivery market statistics, including pharmaceutical drug delivery industry global market size, regional shares, competitors with a pharmaceutical drug delivery market share, detailed pharmaceutical drug delivery market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical drug delivery industry. This pharmaceutical drug delivery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharmaceutical drug delivery market size has grown strongly in recent years. It will grow from $1794.75 billion in 2024 to $1901.48 billion in 2025 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to increase in prevalence of chronic diseases, growing demand for biologics, increase in R&D investments by pharmaceutical companies, rising demand for personalized medicine, increased focus on patient compliance.

The pharmaceutical drug delivery market size is expected to see strong growth in the next few years. It will grow to $2497.33 billion in 2029 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to growing demand for self-administration of drugs, increasing adoption of home healthcare, growing demand for targeted drug delivery, increase in the number of elderly people, regulatory support for drug delivery technologies. Major trends in the forecast period include advancements in drug delivery technologies, telemedicine integration, 3d printing in drug delivery, targeted drug delivery systems, continuous manufacturing processes.

The anticipated rise in the prevalence of chronic diseases is set to drive the growth of the pharmaceutical drug delivery market in the foreseeable future. The term 'prevalence of chronic diseases' denotes the total number of existing cases of chronic diseases within a specific population at a given time. Pharmaceutical drug delivery plays a crucial role in aiding patients suffering from chronic diseases by administering pharmaceutical drugs to specific areas of the body to treat various conditions. For example, the World Health Organization reports that noncommunicable diseases are responsible for 41 million deaths annually, accounting for 71% of all global deaths, with cardiovascular diseases being the leading cause. Therefore, the increasing prevalence of chronic diseases is a key factor propelling the growth of the pharmaceutical drug delivery market.

The continued expansion of telemedicine services is expected to contribute to the growth of the pharmaceutical drug delivery market. Telemedicine involves utilizing technology, such as telecommunication equipment and digital platforms, to provide remote healthcare advice, evaluations, therapy, and follow-up to patients. Integrating pharmaceutical drug delivery systems with telemedicine enhances the efficiency of healthcare delivery, ensuring that patients receive the necessary drugs, support, and advice even when they are geographically separated from healthcare practitioners or facilities. For instance, in August 2022, the Australian Digital Health Agency reported that 118. 2 million telehealth therapy services were provided to 18 million people between March 2020 and July 2022. More than 95,000 practitioners currently utilize telehealth services. Thus, the increasing adoption of telemedicine services is a driving force behind the pharmaceutical drug delivery market.

Leading companies in the pharmaceutical drug delivery market are increasingly adopting strategic partnerships to explore new transport targets and shuttle molecules, enhancing the delivery of medicines to the brain. Strategic partnerships involve companies utilizing each other's strengths and resources to achieve mutual benefits and success. For example, in September 2023, Cordance Medical, a US-based medical equipment manufacturer, entered into a strategic partnership with EXACT Therapeutics to facilitate drug delivery to the brain. This collaboration merges Cordance Medical's NeuroAccess platform, which can non-surgically open the blood-brain barrier (BBB), with EXACT Therapeutics' Acoustic Cluster Therapy (ACT) technology. The partnership aims to improve treatments for brain diseases, including tumors and neurodegenerative disorders, by making it easier for drugs to penetrate the brain. EXACT Therapeutics is a UK-based, clinical-stage biopharmaceutical company.

Major companies operating in the pharmaceutical drug delivery market are focusing on developing innovative products, such as the dual-chamber bag delivery system, to better meet the needs of their existing consumers. Dual-chamber bags are specialized containers designed for storing and delivering medications or medicinal solutions within drug delivery systems. For instance, in June 2022, Gufic Biosciences Limited introduced a new medication delivery system, Dual Chamber Bags, in India. These bags are two-chamber IV bags made of polypropylene (DEHP-free) with peelable aluminum foil, allowing the storage of unstable medications requiring reconstitution just before delivery. The peelable seal keeps the lyophilized (or powdered) medication and its diluent separate, ensuring compliance with American and EU pharmacopeias and meeting ISO7 clean room standards under cGMP.

In May 2022, Halozyme Therapeutics, a US-based biotechnology company, acquired Antares Pharma for $960 million. This strategic acquisition aims to strengthen Halozyme's position as a leading drug delivery company by incorporating Antares' specialty products. Antares Pharma is a US-based specialty pharmaceutical drug delivery company.

Major companies operating in the pharmaceutical drug delivery market include 3M Company., AbbVie Inc., Amgen Inc., AstraZeneca plc, Bayer AG, Becton Dickinson And Company, C. H. Boehringer Sohn AG & Co. KG, Boston Scientific Corporation, Bristol-Myers Squibb Company, Consort Medical plc, Eli Lilly and Company, Emergent Biosolutions Inc., F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Johnson & Johnson, Kite Pharma Inc., Merck & Co Inc., Nemera France SAS, Novartis AG, Pfizer Inc, Sanofi S. A., SHL Medical AG, Teva Pharmaceuticals Industries Ltd., West Pharmaceutical Services Inc., Aerogen Pharma Limited, AptarGroup Inc., Biocon Ltd., Catalent Inc., Evonik Industries AG, Inovio Pharmaceuticals Inc., Mylan NV, Sensile Medical Inc., Ypsomed Holding AG

North America was the largest region in the pharmaceutical drug delivery market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical drug delivery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the pharmaceutical drug delivery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The pharmaceutical drug delivery market includes revenues earned by entities by administering a pharmaceutical compound to achieve a therapeutic effect. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical Drug Delivery Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmaceutical drug delivery market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical drug delivery ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceutical drug delivery market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Route Of Administration: Oral; Ocular; Pulmonary; Nasal; Injectable; Topical; Other Routes
• 2) By Application: Infectious Diseases; Cancer; Cardiovascular Diseases; Diabetes; Respiratory Diseases; Central Nervous System Disorders; Autoimmune Diseases; Other Applications
• 3) By End-User: Hospitals; Home Care Settings; ASC Or Clinics; Other End Users
• Subsegments:
• 1) By Oral: Tablets; Capsules; Liquids; Powders
• 2) By Ocular: Eye Drops; Ocular Inserts; Ocular Implants
• 3) By Pulmonary: Metered-Dose Inhalers (MDIs); Dry Powder Inhalers (DPIs); Nebulizers
• 4) By Nasal: Nasal Sprays; Nasal Gels; Nasal Powders
• 5) By Injectable: Intravenous (IV) Injections; Intramuscular (IM) Injections; Subcutaneous (SC) Injections; Biologics And Biosimilars
• 6) By Topical: Creams; Ointments; Gels; Transdermal Patches
• 7) By Other Routes: Sublingual; Buccal; Rectal; Intranasal
• Companies Mentioned: 3M Company.; AbbVie Inc.; Amgen Inc.; AstraZeneca plc; Bayer AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharmaceutical Drug Delivery Market Characteristics

3. Pharmaceutical Drug Delivery Market Trends And Strategies

4. Pharmaceutical Drug Delivery Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Pharmaceutical Drug Delivery Growth Analysis And Strategic Analysis Framework

• 5.1. Global Pharmaceutical Drug Delivery PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Pharmaceutical Drug Delivery Market Growth Rate Analysis
• 5.4. Global Pharmaceutical Drug Delivery Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Pharmaceutical Drug Delivery Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Pharmaceutical Drug Delivery Total Addressable Market (TAM)

6. Pharmaceutical Drug Delivery Market Segmentation

• 6.1. Global Pharmaceutical Drug Delivery Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Ocular
• Pulmonary
• Nasal
• Injectable
• Topical
• Other Routes
• 6.2. Global Pharmaceutical Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Infectious Diseases
• Cancer
• Cardiovascular Diseases
• Diabetes
• Respiratory Diseases
• Central Nervous System Disorders
• Autoimmune Diseases
• Other Applications
• 6.3. Global Pharmaceutical Drug Delivery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Home Care Settings
• ASC/Clinics
• Other End Users
• 6.4. Global Pharmaceutical Drug Delivery Market, Sub-Segmentation Of Oral, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablets
• Capsules
• Liquids
• Powders
• 6.5. Global Pharmaceutical Drug Delivery Market, Sub-Segmentation Of Ocular, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Eye Drops
• Ocular Inserts
• Ocular Implants
• 6.6. Global Pharmaceutical Drug Delivery Market, Sub-Segmentation Of Pulmonary, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Metered-Dose Inhalers (MDIs)
• Dry Powder Inhalers (DPIs)
• Nebulizers
• 6.7. Global Pharmaceutical Drug Delivery Market, Sub-Segmentation Of Nasal, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nasal Sprays
• Nasal Gels
• Nasal Powders
• 6.8. Global Pharmaceutical Drug Delivery Market, Sub-Segmentation Of Injectable, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intravenous (IV) Injections
• Intramuscular (IM) Injections
• Subcutaneous (SC) Injections
• Biologics And Biosimilars
• 6.9. Global Pharmaceutical Drug Delivery Market, Sub-Segmentation Of Topical, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Creams
• Ointments
• Gels
• Transdermal Patches
• 6.10. Global Pharmaceutical Drug Delivery Market, Sub-Segmentation Of Other Routes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sublingual
• Buccal
• Rectal
• Intranasal

7. Pharmaceutical Drug Delivery Market Regional And Country Analysis

• 7.1. Global Pharmaceutical Drug Delivery Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Pharmaceutical Drug Delivery Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pharmaceutical Drug Delivery Market

• 8.1. Asia-Pacific Pharmaceutical Drug Delivery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pharmaceutical Drug Delivery Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Pharmaceutical Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Pharmaceutical Drug Delivery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pharmaceutical Drug Delivery Market

• 9.1. China Pharmaceutical Drug Delivery Market Overview
• 9.2. China Pharmaceutical Drug Delivery Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Pharmaceutical Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Pharmaceutical Drug Delivery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pharmaceutical Drug Delivery Market

• 10.1. India Pharmaceutical Drug Delivery Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Pharmaceutical Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Pharmaceutical Drug Delivery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pharmaceutical Drug Delivery Market

• 11.1. Japan Pharmaceutical Drug Delivery Market Overview
• 11.2. Japan Pharmaceutical Drug Delivery Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Pharmaceutical Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Pharmaceutical Drug Delivery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pharmaceutical Drug Delivery Market

• 12.1. Australia Pharmaceutical Drug Delivery Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Pharmaceutical Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Pharmaceutical Drug Delivery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pharmaceutical Drug Delivery Market

• 13.1. Indonesia Pharmaceutical Drug Delivery Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Pharmaceutical Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Pharmaceutical Drug Delivery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pharmaceutical Drug Delivery Market

• 14.1. South Korea Pharmaceutical Drug Delivery Market Overview
• 14.2. South Korea Pharmaceutical Drug Delivery Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Pharmaceutical Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Pharmaceutical Drug Delivery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pharmaceutical Drug Delivery Market

• 15.1. Western Europe Pharmaceutical Drug Delivery Market Overview
• 15.2. Western Europe Pharmaceutical Drug Delivery Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Pharmaceutical Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Pharmaceutical Drug Delivery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pharmaceutical Drug Delivery Market

• 16.1. UK Pharmaceutical Drug Delivery Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Pharmaceutical Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Pharmaceutical Drug Delivery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pharmaceutical Drug Delivery Market

• 17.1. Germany Pharmaceutical Drug Delivery Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Pharmaceutical Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Pharmaceutical Drug Delivery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pharmaceutical Drug Delivery Market

• 18.1. France Pharmaceutical Drug Delivery Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Pharmaceutical Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Pharmaceutical Drug Delivery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pharmaceutical Drug Delivery Market

• 19.1. Italy Pharmaceutical Drug Delivery Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Pharmaceutical Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Pharmaceutical Drug Delivery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pharmaceutical Drug Delivery Market

• 20.1. Spain Pharmaceutical Drug Delivery Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Pharmaceutical Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Pharmaceutical Drug Delivery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pharmaceutical Drug Delivery Market

• 21.1. Eastern Europe Pharmaceutical Drug Delivery Market Overview
• 21.2. Eastern Europe Pharmaceutical Drug Delivery Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Pharmaceutical Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Pharmaceutical Drug Delivery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pharmaceutical Drug Delivery Market

• 22.1. Russia Pharmaceutical Drug Delivery Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Pharmaceutical Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Pharmaceutical Drug Delivery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pharmaceutical Drug Delivery Market

• 23.1. North America Pharmaceutical Drug Delivery Market Overview
• 23.2. North America Pharmaceutical Drug Delivery Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Pharmaceutical Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Pharmaceutical Drug Delivery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pharmaceutical Drug Delivery Market

• 24.1. USA Pharmaceutical Drug Delivery Market Overview
• 24.2. USA Pharmaceutical Drug Delivery Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Pharmaceutical Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Pharmaceutical Drug Delivery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pharmaceutical Drug Delivery Market

• 25.1. Canada Pharmaceutical Drug Delivery Market Overview
• 25.2. Canada Pharmaceutical Drug Delivery Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Pharmaceutical Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Pharmaceutical Drug Delivery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pharmaceutical Drug Delivery Market

• 26.1. South America Pharmaceutical Drug Delivery Market Overview
• 26.2. South America Pharmaceutical Drug Delivery Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Pharmaceutical Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Pharmaceutical Drug Delivery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pharmaceutical Drug Delivery Market

• 27.1. Brazil Pharmaceutical Drug Delivery Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Pharmaceutical Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Pharmaceutical Drug Delivery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pharmaceutical Drug Delivery Market

• 28.1. Middle East Pharmaceutical Drug Delivery Market Overview
• 28.2. Middle East Pharmaceutical Drug Delivery Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Pharmaceutical Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Pharmaceutical Drug Delivery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pharmaceutical Drug Delivery Market

• 29.1. Africa Pharmaceutical Drug Delivery Market Overview
• 29.2. Africa Pharmaceutical Drug Delivery Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Pharmaceutical Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Pharmaceutical Drug Delivery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pharmaceutical Drug Delivery Market Competitive Landscape And Company Profiles

• 30.1. Pharmaceutical Drug Delivery Market Competitive Landscape
• 30.2. Pharmaceutical Drug Delivery Market Company Profiles
  • 30.2.1. 3M Company. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Pharmaceutical Drug Delivery Market Other Major And Innovative Companies

• 31.1. Becton Dickinson And Company
• 31.2. C. H. Boehringer Sohn AG & Co. KG
• 31.3. Boston Scientific Corporation
• 31.4. Bristol-Myers Squibb Company
• 31.5. Consort Medical plc
• 31.6. Eli Lilly and Company
• 31.7. Emergent Biosolutions Inc.
• 31.8. F. Hoffmann-La Roche AG
• 31.9. GlaxoSmithKline plc
• 31.10. Johnson & Johnson
• 31.11. Kite Pharma Inc.
• 31.12. Merck & Co Inc.
• 31.13. Nemera France SAS
• 31.14. Novartis AG
• 31.15. Pfizer Inc

32. Global Pharmaceutical Drug Delivery Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pharmaceutical Drug Delivery Market

34. Recent Developments In The Pharmaceutical Drug Delivery Market

35. Pharmaceutical Drug Delivery Market High Potential Countries, Segments and Strategies

• 35.1 Pharmaceutical Drug Delivery Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Pharmaceutical Drug Delivery Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Pharmaceutical Drug Delivery Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer